What is Lumicks?
Lumicks operates at the intersection of advanced physics and biological research, specializing in the development of sophisticated equipment for Dynamic Single-Molecule and Cell Avidity analysis. These technologies are essential for researchers aiming to observe biological interactions in real-time, providing unprecedented insights into molecular mechanisms. By focusing on these high-growth niches, the company has established a robust market position, particularly within the competitive landscape of immuno-oncology and drug discovery, where precision measurement is a prerequisite for therapeutic success.
How much funding has Lumicks raised?
Lumicks has raised a total of $93M across 1 funding round:
Series D
$93M
Series D (2021): $93M with participation from Pura Vida Investments LLC, Lauxera Capital Partners, Irving Investors, and Farallon Capital Management LLC
Key Investors in Lumicks
Pura Vida Investments LLC
A specialized investment firm focused on identifying high-growth opportunities within the healthcare and life sciences sectors.
Lauxera Capital Partners
A growth-oriented private equity firm that partners with innovative health-tech companies to drive international expansion.
Irving Investors
An investment management firm that provides strategic capital to companies demonstrating significant technological disruption in their respective markets.
What's next for Lumicks?
With the successful closure of its latest financing round, Lumicks is well-positioned to accelerate its commercial expansion and R&D initiatives. The company is expected to leverage this capital to enhance its global distribution network and further refine its single-molecule analysis platforms. As the demand for high-resolution biological data grows, Lumicks is likely to focus on scaling its manufacturing capabilities and expanding its application portfolio to address emerging challenges in complex disease research, thereby cementing its role as a cornerstone of modern life science instrumentation.
See full Lumicks company page
